17%OFF
Stock image for illustration purposes only - book cover, edition or condition may vary.
Antidepressant Era
David Healy
FREE Delivery in Ireland
Description for Antidepressant Era
Paperback. An account of the phenomenon of antidepressants. The book chronicles the history of psychopharmacology and the current debate over drugs replacing psychotherapy, and explores the regulation of drug companies, what antidepressants reveal about the human brain and the sociology of drug marketing. Num Pages: 336 pages, 6 line illustrations. BIC Classification: JHM; MBX; MMGW; MMJT. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 234 x 156 x 20. Weight in Grams: 478.
When we stop at the pharmacy to pick up our Prozac, are we simply buying a drug? Or are we buying into a disease as well? The first complete account of the phenomenon of antidepressants, this authoritative, highly readable book relates how depression, a disease only recently deemed too rare to merit study, has become one of the most common disorders of our day--and a booming business to boot.
The Antidepressant Era chronicles the history of psychopharmacology from its inception with the discovery of chlorpromazine in 1951 to current battles over whether these powerful chemical compounds should replace psychotherapy. ... Read moreAn expert in both the history and the science of neurochemistry and psychopharmacology, David Healy offers a close-up perspective on early research and clinical trials, the stumbling and successes that have made Prozac and Zoloft household names. The complex story he tells, against a backdrop of changing ideas about medicine, details the origins of the pharmaceutical industry, the pressures for regulation of drug companies, and the emergence of the idea of a depressive disease. This historical and neurochemical analysis leads to a clear look at what antidepressants reveal about both the workings of the brain and the sociology of drug marketing.
Most arresting is Healy's insight into the marketing of antidepressants and the medicalization of the neuroses. Demonstrating that pharmaceutical companies are as much in the business of selling psychiatric diagnoses as of selling psychotropic drugs, he raises disturbing questions about how much of medical science is governed by financial interest.
Show Less
Product Details
Publisher
Harvard University Press United States
Place of Publication
Cambridge, Mass, United States
Shipping Time
Usually ships in 7 to 11 working days
About David Healy
David Healy is Reader in Psychological Medicine at North Wales Clinical School and a former Secretary of the British Association for Psychopharmacology.
Reviews for Antidepressant Era
David Healy's book focuses on the discovery and development of antidepressants and provides a fascinating insight into the history of this field. He skillfully interweaves the account of the roles played by the key scientists and clinicians with the powerful influence of pharmaceutical companies... The antidepressant era represents one of the seminal events in the social and cultural history of ... Read morethe latter half of the twentieth century. This book is written in an individual and engaging style and the author reveals a deep knowledge of his subject; he has his own firm views but does not force them upon the reader. I found it a compelling read and hope that it will reach a wide audience.
Leslie Iversen
Nature
As a history, it is brilliant and brilliantly written, tracing the introduction of antidepressants, which, along with the first antibiotics and antihypertensives, created a therapeutic revolution just after World War II. These developments brought health to the center of global politics and created the possibility of a common language that crossed ethnic, race, and class barriers. The paths traced begin in antiquity. Healy discusses concepts of disease and illness beginning with Hippocrates; the isolation of the tubercle bacillus by Robert Koch; the beginning of the pharmaceutical companies; (In 1804, there were 90 patent medicines listed. By 1857, the list had grown to 1,500); the discovery of the power of marketing with aspirin; the 1951 bill which gave the FDA power to decide which medicines should be made available by prescription; and the 1962 Kefauver-Harris amendment which charged the FDA with establishing the efficacy of over-the-counter as well as prescription drugs. The role of NIMH in testing the new psychotropic drugs, the discovery and testing of the antidepressants and the science developed to facilitate testing are well described. Since many of the scientists who participated in the antidepressant revolution were still around for interviewing, the material is vivid and personal.
Myrna M. Weissman
New England Journal of Medicine
In the past five years [David Healy] has emerged as the leading international authority on the history of psychopharmacology...Healy's modest endnotes reveal that he has participated in numerous key events, and that he knows personally many of the main actors in the story...The body of Healy's book is a clear, detailed and highly informative reconstruction of the major lines of clinical and laboratory research that have produced modern psychiatric pharmacotherapy...Healy is well-informed...Without slighting the science, he manages to describe [major developments] in an admirably readable narrative...The best remedies of all, however, may be a historically informed medical profession and a biomedically enlightened public. David Healy's impressive and fascinating book is a means to these ends.
Mark S. Micale
Times Literary Supplement
David Healy is one of the most remarkable figures in contemporary psychiatry. He combines the skills of an historian with a training in laboratory psychopharmacology, a research interest in psychopathology, and an encyclopedic knowledge of the psychotherapies. Throughout the past decade he has published books and papers on subjects as diverse as phenomenology, nosology, hysteria, and psychopharmacology...Healy's trilogy [The Psychopharmacologists,The Psychopharmacologists II, and The Antidepressant Era] is a major achievement: its importance goes beyond psychiatry and psychopharmacology to embrace the whole of medicine. These books represent a quantum leap in understanding the processes that shape therapeutic innovation in clinical practice. Work of this revolutionary scope comes along infrequently
perhaps once in a decade.
Bruce G.Charlton
Journal of Medicine of the Royal Society
The story Healy brilliantly recounts is one of increasing regulation of psychopharmaceuticals by governments...Healy's proposal will strike some as unscientific and others as humane, for he calls for the deregulation of psychoactive drugs, thereby putting control of mental illness back in the people's hands and forcing physicians to refocus their efforts on cultivating an empathic clinical encounter. In doing so, as Healy rightly claims, patients are better served and mental illness is better understood.
Robert A. Crouch
Religious Studies Reviews
Well-written and thoroughly researched, the book provides an excellent overview of the history of psychotropic medicine from Hippocrates to the age of Prozac, using depression as a paradigm of the ways in which the popularity of such drugs may have been influenced more by pharmaceutical marketing than by medical necessity.
Catherine Calloway
Journal of American Culture
Show Less
.png){kind=logo}